Fig. 2
From: Pretreatment of UC-MSCs with IFN-α2 improves treatment of liver fibrosis by recruiting neutrophils
IFN-α2 induced changes inflammatory factor expression of UC-MSCs. A Analysis of IFN-α2 content in serum from patients with liver cirrhosis (n = 10) and healthy donors (n = 30). B Effects of different concentrations on the activity of UC-MSCs. C Relative mRNA expression levels of inflammatory factors in UC-MSCs treated with 5 ng/mL IFN-α2 and 10 ng/mL IFN-α2. D ELISA Analysis of CCL2 protein secretion levels in cell suprnatant after treated with 5 ng/mL IFN-α2 and 10 ng/mL IFN-α2. *P < 0.05, **P < 0.01, ***P < 0.001